# Novartis operating income entity: /record/novartis.md predicate: operating_income page: /record/novartis/operating_income as_of: 2026-11-09 cite: AsOf. "Novartis operating income: 17,644,000,000 United States dollar", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm. As of November 9, 2026, Novartis's operating income on the AsOf record is $17.64 billion, dated December 31, 2025, from a primary source (sec.gov). 10 claims on Novartis's operating income, 1 open and 9 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current operating income What the record asserts on 2026-11-09. - [Novartis](/record/novartis.md) | operating_income | 17,644,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_13AEEBEB19A6](/claim/clm_13AEEBEB19A6.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Novartis](/record/novartis.md) | operating_income | 8,268,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_0526738C57FA](/claim/clm_0526738C57FA.md) | [clm_EE8DEE22E155](/claim/clm_EE8DEE22E155.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | operating_income | 8,629,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_D3E230AFF547](/claim/clm_D3E230AFF547.md) | [clm_0526738C57FA](/claim/clm_0526738C57FA.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | operating_income | 8,169,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_0149AA2021B4](/claim/clm_0149AA2021B4.md) | [clm_D3E230AFF547](/claim/clm_D3E230AFF547.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm - [Novartis](/record/novartis.md) | operating_income | 9,086,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_ADC8AC894691](/claim/clm_ADC8AC894691.md) | [clm_0149AA2021B4](/claim/clm_0149AA2021B4.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm - [Novartis](/record/novartis.md) | operating_income | 10,152,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_E1378382005A](/claim/clm_E1378382005A.md) | [clm_ADC8AC894691](/claim/clm_ADC8AC894691.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/0001370368-21-000006-index.htm - [Novartis](/record/novartis.md) | operating_income | 11,689,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_9BE780A31D35](/claim/clm_9BE780A31D35.md) | [clm_E1378382005A](/claim/clm_E1378382005A.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/0001370368-22-000010-index.htm - [Novartis](/record/novartis.md) | operating_income | 9,197,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_C54C261844E4](/claim/clm_C54C261844E4.md) | [clm_9BE780A31D35](/claim/clm_9BE780A31D35.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/0001370368-23-000006-index.htm - [Novartis](/record/novartis.md) | operating_income | 9,769,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md) | [clm_C54C261844E4](/claim/clm_C54C261844E4.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/0001370368-24-000004-index.htm - [Novartis](/record/novartis.md) | operating_income | 14,544,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_13AEEBEB19A6](/claim/clm_13AEEBEB19A6.md) | [clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm - [Novartis](/record/novartis.md) | operating_income | 17,644,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_13AEEBEB19A6](/claim/clm_13AEEBEB19A6.md) sources: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm ## What replaced what - $8.27 billion (2016-12-31 to 2017-12-31, [clm_EE8DEE22E155](/claim/clm_EE8DEE22E155.md)) was replaced by $8.63 billion from 2017-12-31 ([clm_0526738C57FA](/claim/clm_0526738C57FA.md)) - $8.63 billion (2017-12-31 to 2018-12-31, [clm_0526738C57FA](/claim/clm_0526738C57FA.md)) was replaced by $8.17 billion from 2018-12-31 ([clm_D3E230AFF547](/claim/clm_D3E230AFF547.md)) - $8.17 billion (2018-12-31 to 2019-12-31, [clm_D3E230AFF547](/claim/clm_D3E230AFF547.md)) was replaced by $9.09 billion from 2019-12-31 ([clm_0149AA2021B4](/claim/clm_0149AA2021B4.md)) - $9.09 billion (2019-12-31 to 2020-12-31, [clm_0149AA2021B4](/claim/clm_0149AA2021B4.md)) was replaced by $10.15 billion from 2020-12-31 ([clm_ADC8AC894691](/claim/clm_ADC8AC894691.md)) - $10.15 billion (2020-12-31 to 2021-12-31, [clm_ADC8AC894691](/claim/clm_ADC8AC894691.md)) was replaced by $11.69 billion from 2021-12-31 ([clm_E1378382005A](/claim/clm_E1378382005A.md)) - $11.69 billion (2021-12-31 to 2022-12-31, [clm_E1378382005A](/claim/clm_E1378382005A.md)) was replaced by $9.2 billion from 2022-12-31 ([clm_9BE780A31D35](/claim/clm_9BE780A31D35.md)) - $9.2 billion (2022-12-31 to 2023-12-31, [clm_9BE780A31D35](/claim/clm_9BE780A31D35.md)) was replaced by $9.77 billion from 2023-12-31 ([clm_C54C261844E4](/claim/clm_C54C261844E4.md)) - $9.77 billion (2023-12-31 to 2024-12-31, [clm_C54C261844E4](/claim/clm_C54C261844E4.md)) was replaced by $14.54 billion from 2024-12-31 ([clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md)) - $14.54 billion (2024-12-31 to 2025-12-31, [clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md)) was replaced by $17.64 billion from 2025-12-31 ([clm_13AEEBEB19A6](/claim/clm_13AEEBEB19A6.md)) ## Questions this record answers ### What is Novartis's current operating income? $17.64 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95). ### When did Novartis's operating income last change? The latest value on the record is $17.64 billion, dated December 31, 2025; before it the record holds $14.54 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Novartis's operating income before $17.64 billion? $14.54 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/novartis/operating_income (markdown: /record/novartis/operating_income.md) - Entity twin: /record/novartis.md ยท timeline: /timelines/novartis.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.